Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.66%
#2 Venom Venom +22.52%
#3 aelf aelf +12.97%
#4 TRIA TRIA +8.74%
#5 Decred Decred +7.98%
#6 Status Status +7.87%
#7 DexNet DexNet +7.56%
#8 MarsCoin MarsCoin +7.36%
#9 Pons Pons +7.15%
#10 Wibx Wibx +5.97%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Nanologica AB (publ) Nanologica AB (publ)

Nanologica AB (publ)

NICA
Rangering i aksjer #30458
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and... Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Aksjekurs
$0.05093225
Sist synkronisert: 2026-08-18
Markedsverdi
$16.74M
Endring (1 dag)
1.11%
Endring (1 år)
-68.04%
Land
SE
Handel Nanologica AB (publ) (NICA)

Kategori

Healthcare
Inntekter for Nanologica AB (publ) (NICA)
Inntekter i 2026 TTM: 0
Ifølge Nanologica AB (publ) sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Nanologica AB (publ) fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT